Armada Acquisition Corp. II (XRPNW)
The warrant ticker XRPNW represents the call-option half of Armada Acquisition Corp. II’s unit structure. Where XRPNU bundles a share and a warrant together, XRPNW trades independently once the units separate, allowing investors to isolate and trade the warrant portion. A warrant is a derivative — it is the right, but not the obligation, to purchase a share of the underlying company at a fixed price (the strike) within a fixed time period. For a SPAC warrant, the underlying company is whatever entity emerges from a successful acquisition and merger.
The appeal of warrants to SPAC investors lies in their leverage and asymmetric payoff. If an investor buys a unit at $10 and holds both the share and the warrant, the share provides downside protection — it can usually be redeemed for roughly the initial $10 if the deal fails or is bad enough to prompt redemptions. The warrant, by contrast, has no redemption right; it either becomes valuable if the merged company’s stock rises above the strike price, or it expires worthless. This combination gives sponsors and early investors a free option on upside while capping their downside, a powerful economic driver for deal-making.
Mechanically, a SPAC warrant is typically exercisable on a one-for-one basis — one warrant gives the right to buy one share at a fixed strike, usually in the $11 to $12 range, for a period of several years. If the merged company trades at $20 per share, the warrant is worth at least $8 to $9 (the difference between $20 and the strike, minus the cost of exercise if applicable). But if the stock trades at $10 or below the strike, the warrant is out-of-the-money and worth little more than its time value — the possibility that it could move above the strike before expiration.
The warrant holders include the SPAC sponsor team, who retain founder warrants as an incentive; institutional investors in the initial IPO; and retail traders who buy warrants as a leveraged bet on the post-merger stock. This creates a complex incentive structure. Sponsors are motivated to close a deal at almost any price because they only profit if a merger succeeds; warrant holders bet that the deal will create real value and the stock will rise well above the strike; and the merged company’s operating team (usually brought in from the acquired business) are focused on executing the business plan. When a merger closes, the interests of these groups can diverge sharply. Heavy redemptions by common-stock shareholders can leave the merged company undercapitalized; sponsors may extract cash through advisory fees; and the warrant holder is left betting on whether the operational team can create value faster than capital markets are currently pricing in.
Post-merger warrant performance has been notably poor across the SPAC universe. Many warrants have expired worthless or nearly so, for several reasons. First, the dilution from sponsor shares and the warrant pool itself means that to create real per-share value, the merged company must grow faster or more profitably than a comparable public company, a high bar. Second, the initial strike prices were typically set optimistic about post-merger performance, and many merged companies have underperformed those early expectations. Third, the time decay — the warrant loses value as it approaches its expiration date if the stock remains near the strike — means that a flat or slowly recovering stock will watch its warrants deflate over the holding period. Finally, many merged companies faced operational challenges, capital constraints from redemptions, or competitive pressures that prevented them from reaching the valuations that would have made warrant holders whole.
For investors holding or considering XRPNW, the exercise is one of assessing both the SPAC structure and the likely quality of the acquisition target. A warrant on a SPAC with a strong sponsor team, a large trust account, and a genuinely strategic acquisition target has a higher probability of reaching a profitable outcome than a warrant on a hastily formed blank-check company with a vague acquisition strategy. Even so, the warrant is a leveraged bet, and leverage cuts both ways: leverage amplifies gains when the underlying stock rises sharply, but it accelerates losses as the position moves against the holder, particularly as expiration approaches. The ability to diversify warrant positions, and to accept that many will expire worthless, is essential for warrant investors to avoid catastrophic outcomes in any single position.
The warrant’s economic role in the SPAC ecosystem is to provide the sponsor and early investors with a kicker for the effort and capital at risk in forming and operating a blank-check company. For later investors who buy warrants on the secondary market, the warrant is purely a speculative bet on the merged company’s operational success and the stock price rising above the strike before expiration. That distinction — sponsor incentive versus speculative derivative — is central to understanding why warrant values can diverge so sharply from common-share values in the months and years after a merger closes.